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Abstract Aneuploidy is common and may be a natural oc-
currence in early human embryos. Selecting against embryos
containing aneuploid cells for embryo transfer has been re-
ported to increase clinical pregnancies per transfer in some
studies, but not others. Some aneuploidy is due to misalloca-
tion of chromosomes during meiosis, in either the egg or
sperm, but most aneuploidy is due to misallocation of chro-
mosomes during mitoses after fertilization. Big questions are
as follows:Why does this happen? Howmuch aneuploidy in a
preimplantation embryo is compatible with normal fetal de-
velopment? Is aneuploidy increased by in vitro culture, and/or
could it be prevented or corrected in the IVF lab?
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Background
Signaling the mother that it is developing is arguably the sin-
gle most important activity of a fertilized human egg. The
signal must be timely and robust, doubling at least every 2
to 3 days. The best known signal is hCG, but there are prob-
ably others, such as IL4 and IL17b [1].
Without robust, timely, embryo-to-mother signals, a mis-
carriage occurs. This no compromise system conserves mater-
nal resources so precious uterus time is not wasted on a defec-
tive conception—which is common in humans. Such conser-
vation ofmaternal resources is also observed in other placental
mammals, such as mice and sheep. Transfer of one embryo
into a mouse foster mother almost always results in miscar-
riage; mice are designed to carry multiple fetuses, so signals
from a single fertilized egg are not sufficient to maintain her
pregnancy. Similarly with goats and sheep, they almost al-
ways have at least twins, suggesting singleton conceptions
do not generate enough pregnancy signal to maintain a preg-
nant state.
How does a fertilized egg accomplish increasing signals to
the mother? Starting with only one full set of chromosomes,
there are three possibilities: (1) redundant copies of the
maternal-signaling genes are quickly synthesized, an hypoth-
esis in keeping with Nobel Laureate Howard Temin’s views
[2], and supported by frog development in which multiple
copies of ribosomal genes are synthesized early after fertiliza-
tion [3]; or (2) transcription and translation from the maternal-
signaling genes are preferentially enhanced immediately after
fertilization; or (3) the entire set of chromosomes is doubled at
least daily, thus doubling the gene dose needed to produce the
embryo-to-mother signal.
In scenario (1), redundant copies of maternal-signaling
genes have not shown up on the many genomic hybridization
studies that have now been reported for human embryos [4] so
that seems less likely, although not proven wrong.
Evidence in support of scenario (2), specific-enhanced tran-
scription and translation of maternal-signaling genes, is lacking,
although this attractive possibility is worthy of further study.
Capsule Aneuploid cells appear to be a natural occurrence during early
mammalian development. The current challenge is to (1) understand the
nature and percentage of aneuploid cells that defeat developmental prog-
ress to a healthy offspring and (2) the role of early development in vitro
that either promotes, or diminishes, aneuploid cell divisions.
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Human eggs undergo the first cell division by approximate-
ly 30 h after insemination. The second cell division to four
cells occurs approximately 16 h later, thus accomplishing a
fourfold increase in gene copy number within 48 h [5]. On the
third day, the embryo doubles the copy number again to eight
cells which continue to divide and compact into a morula.
This rate of chromosome doubling supports scenario (3) that
the necessary increase in embryo-to-maternal signal may be
accomplished by corresponding increases in gene copy num-
ber. To facilitate these rapid divisions, there is over-expression
of multiple cell cycle-promoting genes, such as cyclin E,Myc,
and the Aurora kinases [6] and the absence of cell cycle check
points, RB and WEE1 [7, 8].
On day 5 or 6, the human embryo expands into the blasto-
cyst separating into the inner cell mass and the trophectoderm.
At this stage, in vitro developed human embryos are com-
prised of approximately 60 cells, in keeping with cell dou-
blings at least every 24 h following fertilization. If human
embryo development is slowed in vitro, as is the case inmouse
embryos [9], in vivo developed human embryos would be 120
cells at the blastocyst stage, with cell doublings every 18 h.
The lack of cell cycle check points renders the early
embryo susceptible to possible errors in DNA synthesis
and unequal distributions of chromosomes during cleavage
divisions. RB, the retinoblastoma gene, is one of the first
reported human oncogenes [10] and is responsible for cell
cycle arrest in G1, the cell cycle stage in which most so-
matic cells come to rest. Cells are brought out of G1 arrest
by growth factor stimulation of cyclins that, in combination
with their respective kinases, overcome the RB blockade
and promote progression to DNA synthesis. Cells lacking
RB, such as cancer cells, do not require growth factors to
stimulate cell division. The limited detection of canonical
growth factor receptor messages on microarrays of 8-cell
human embryo RNAs [11] further supports the lack of a
growth factor requirement for human blastomeres to pro-
ceed through gap 1, raising the question of what, if any,
cellular controls are in place to ensure the faithful replica-
tion of the chromosomes of the early embryo? A newly
discovered tumor suppressor gene, UHRF2, detected at el-
evated levels on the 8-cell embryo microarrays [8] and
more recently on human oocyte microarrays [12], is an
attractive candidate. UHRF2, a nuclear protein frequently
lost in cancer cells [13] and downregulated in fully differ-
entiated cells, appears to be a central player in the cell cycle
by coordinating the ubiquitin-protease system with methyl-
ated DNA. It has been shown to bring about the degrada-
tion of cyclins D1 and E1, effecting a G1 arrest, and inter-
acts specifically with hemi-methylated DNA [14]. The dis-
covery of UHRF2 expression in 8-cell human embryos
lacking RB suggests a unique role for this interesting nu-
clear protein that apparently connects several cell cycle pro-
cesses with the methylation state of the DNA.
Over-expression of geminin may guard against errors in
DNA replication during S phase [6]. The silence of the G2
checkpoint, WEE1, raises concerns about what elements are
in place to support accurate allocation of chromosomes to
daughter cells. High levels of detection of aurora kinase
mRNAs, major players in centrosome duplication and forma-
tion of the mitotic spindle, suggest rapid progress through G2.
Kinase activities may be modulated by over-expression of
Incenp (inner centrosome passenger protein) and Stag pro-
teins, included in cohesion, and the Pttg proteins to block
separase activity, to allow sufficient time for accurate chromo-
some attachment and line up at anaphase. Nonetheless, the
over-expression of aurora kinase genes, in combination with
over expression of cell cycle drivers such as cyclin E andMyc,
is a recipe for unequal chromosome allocation to daughter
cells, and cytoplasmic fragments.
The dependence of the human egg on the fertilizing sperm
to be the source of the centrosome, responsible for the two
centrioles needed to generate the spindle microtubules for the
first mitotic division, emphasizes the importance of the sperm
for the first euploid cleavage, a couple of cell cycles before the
onset of paternal gene expression [15].
Embryonic aneuploidy
A systematic review and meta-analysis of chromosomal
studies of human embryos in 2011 reported that 73% of
all human embryos resulting from IVF contain some an-
euploid cells [16, 17]. What are the consequences to the
early embryo of an unequal distribution of chromosomes
among the blastomeres? The answer to this important
question is not simple. Approximately 20% of human
eggs and 9% of human sperm are thought to be aneuploid
[18]. If embryo aneuploidy is due to an error in meiosis,
estimated to account for about 25% of observed embryo
aneuploidy [19], it will persist and affect every blasto-
mere, unless aneuploidy-correcting mechanisms can be
activated. Sperm meiosis occurs continually in the adult
male testis, and circumstances contributing to misalloca-
tion of chromosomes during male meiosis are not under-
stood. The development of methods of evaluating the
chromosome content of individual sperm heads have re-
vealed a measurable incidence of chromosome loss in
sperm [20], suggesting failure during meiosis to capture
all the chromosomes into new nuclei following anaphase.
Egg meiosis resumes during the final stages of egg
maturation, just prior to ovulation. Half of the egg chro-
mosomes are extruded into the first polar body, complet-
ing meiosis I, and the egg immediately enters meiosis II,
arresting at metaphase II until fertilization. The metaphase
arrest is due to the action of the protooncogene kinase,
cMos [21]. Sperm entry into the cytoplasm leads to a
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reduction in cMos activity, allowing chromosome separa-
tion and the extrusion of the second polar body. Errors in
anaphase at either meiosis I or meiosis II have been
shown to occur more frequently with advancing maternal
age [22]. Some studies, but not others, have suggested
that the ovulation induction protocols used for standard
IVF procedures may increase the frequency of meiotic
errors in eggs, thus secondarily increasing aneuploidy in
the resulting embryos [23, 24].
If the newly fertilized egg is missing a chromosome
from either the sperm or the egg, it would need to be
specifically duplicated to give rise to euploid blastomeres.
If three copies of any chromosome are present, one would
need to be eliminated, or the fertilized egg would have to
silence one chromosome copy to avoid over-expression of
those genes, perhaps in a manner analogous to the X
chromosome inactivation that occurs in female embryo
cells. Aneuploidies in which only one copy of a chromo-
some from either sperm or egg is present are apparently
not compatible with fetal development, with the exception
of the X chromosome. Turner’s syndrome, in which fe-
males have a single X chromosome, occurs in 1 in 2000
female births. The majority of Turner’s patients have the
maternal X chromosome [25, 26], suggesting the fertiliz-
ing sperm was missing a sex chromosome. In contrast,
aneuploidies with three copies of one chromosome sup-
port some fetal development, such as trisomy 13, 18, and
21, although only trisomy 21 (Down’s syndrome) is actu-
ally compatible with development into adulthood.
Aneuploidy arising during the mitoses that follow fertiliza-
tion are thought to account for the majority of the aneuploidy
observed in preimplantation human embryos. The most likely
anaphase errors appear to be loss of a chromosome poorly
attached to the spindle that does not become enclosed within
the daughter nucleus, and failure of a chromosome to separate
at anaphase. The loss of a chromosome results in one euploid
and one aneuploid cell, whereas failure to separate at anaphase
leads to two aneuploid cells, one with too many chromosomes
and one with too few [15, 17]. It can be argued that the blas-
tomeres contributing to the inner cell mass that will give rise to
the fetus need to be euploid to support normal fetal develop-
ment (Fig. 1). If true, it may be important that the first cleavage
to two cells is euploid to generate a population of euploid
cells. But, should chromosome-correcting pathways be oper-
ational, even this may not be necessary.
Commitment to inner cell mass versus trophoblast be-
gins at approximately the 16-cell stage when one or two
cells become positioned within the ball of blastomeres
(Fig. 1). Hence, during most preimplantation stages, on
the order of only 10% of total cells will give rise to the
fetus. Given the polyploidy and endoreduplication among
trophoblast cells [27], aneuploidy among that cell popula-
tion may not negatively influence further development.
Embryonic genome analyses
Several lines of evidence support the notion that aneuploidy is
common, maybe universal, in early stage mammalian embry-
os. One is the very small fraction of individual blastomeres
from mouse and human embryos competent to continue di-
viding into a stable line of stem cells. In 2006, Lanza and
colleagues biopsied human embryos and reported 2 of 91
blastomeres developed into embryonic stem cell lines [28].
Two years later, van de Velde and colleagues dissociated four
human embryos at the 4-cell stage (16 blastomeres) only two
of which (12%) developed into embryonic stem cell lines, one
normal XYand one mosaic XX [29]. In 2007, Wakayama and
colleagues attempted to isolate mouse embryonic stem cell
lines from individual mouse blastomeres. From six 2-cell
stage embryos, both blastomeres developed into embryonic
stem cell lines from one embryo; one blastomere, but not the
other, from two embryos; and none from the remaining three
embryos. If aneuploidy accounts for the failures, 16% of the 2-
cell mouse embryos were euploid. From three 4-cell stage
embryos, only one blastomere developed into an embryonic
stem cell line (8%), and from six 8-cell embryos, four blasto-
meres from four different embryos (8%) developed into em-
bryonic stem cell lines. In contrast, the same group developed
14 new mouse embryonic stem cell lines from the inner cell
masses of 16 blastocysts.
One explanation for the inability of single blastomeres to
give rise to stable stem cells lines is that cells of the early
embryo require contact with each other for continued devel-
opment, but an equally plausible explanation is that fewer than
20% of the individual blastomeres from mouse and human
eggs are truly euploid and capable of sustaining independent
continued cell division.
Another line of evidence that aneuploidy is common stems
from chromosome analyses of individual blastomeres
biopsied from human embryos at various stages of early de-
velopment. The original goal of the early embryo biopsies was
to analyze the embryo for sex chromosomes, to avoid sex-
linked genetic defects in offspring or specific gene mutations
associated with disease, such as Tay Sachs, cystic fibrosis, or
sickle cell anemia [30–32]. Several research groups reported
removal of one or two blastomeres from early cleaving human
embryos for genetic analyses without apparently reducing the
viability of the embryo itself [33]. Initially, DNA amplifica-
tion with polymerase chain reaction was utilized to detect Y
chromosomes or obtain gene sequences, and soon thereafter,
chromosome analyses were performed on individual blasto-
meres by fluorescence in situ hybridization (FISH).
Because chromosomal analyses of miscarriages demon-
strated that aneuploidy is associated with early pregnancy fail-
ures [34, 35], the blastomere biopsy FISH techniques were
quickly applied to assessing aneuploidy in individual cells of
early embryos in order to transfer only euploid embryos.
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Gianaroli and colleagues showed improvements in implanta-
tion frequencies per embryo transfer by deselecting the aneu-
ploid embryos in poor prognosis patients [36]. Although ini-
tially promising, single cell biopsy of early cleaving embryos
and analysis by FISH of six to eight chromosomes limited this
technology, but supported the notion that aneuploidy is com-
mon in preimplantation embryos. Knowing this, however, did
not seem to improve overall pregnancy outcomes. In a multi-
center, randomized, controlled trial, Matstenbrooke and col-
leagues found that PGS with FISH lowered ongoing pregnan-
cies by 12%. In 2007, the American Society of Reproductive
Medicine stated Bavailable evidence does not support the use
of PGS as currently performed to improve live birth rates in
patients with advanced maternal age, previous implantation
failure, or recurrent pregnancy loss^ [37, 38].
Many of the limitations in early aneuploidy screening
by FISH have been overcome. Culturing the embryo lon-
ger permits trophectoderm (TE) biopsy, which allows
sampling of more cells and is better tolerated by the em-
bryo. This certainly improves the accuracy of detecting
defects in specific genes, but may not reflect the chromo-
some status of the developing fetus. Molecular biology
techniques, such as real-time PCR, single nucleotide poly-
morphism (SNP) analyses, comparative genomic hybridi-
zation (CGH), or, more recently, next generation sequenc-
ing (NGS), have been applied to genetic analyses of three
to five trophoblast cells and shown to be more reliable in
detecting chromosomes than FISH [4, 39]. Real-time PCR
(qPCR) quantifies chromosome copy number of each
chromosome to a reference tissue known to be euploid.
Both SNP and CGH microarrays compare amplified blas-
tomere DNA to a reference tissue known to be euploid;
the readout shows deletions and duplications as a higher
or lower signal compared to the control. More recently, in
NGS, the fragmented DNA is amplified in clusters and
sequenced. The sequences are then aligned with bioinfor-
matics software to reveal deletions or amplifications of
specific chromosomes [40].
The development of more global methods to assess chro-
mosome number has led to more widespread screening of
embryos for aneuploidy. A 2010 comparison of FISH with
SNP analyses of 13 embryos by Richard Scott and colleagues
revealed that 8 of the 13 appeared euploid by SNP analyses
and none were euploid by FISH analyses, confirming not only
the high (at least 38%) incidence of aneuploidy [39], but the
superior accuracy of SNP analyses over FISH analyses. In a
follow-up study, 50 embryos judged to be aneuploid by FISH
at early cleavage stages were allowed to develop further and
re-analyzed at the blastocyst stage by SNP. Only 21 (42%)
were aneuploid by SNP analyses with no apparent preference
for inner cell mass or trophoblast cells [41], supporting the
notion that SNP analyses provided a more accurate assess-
ment of chromosome content, but also suggesting some
aneuploidy-correcting mechanisms may exist in early cleav-
age stage embryos.
The ability to genetically screen a few cells from human
embryos without apparently reducing their developmental po-
tential immediately led to the question of whether transfer of
only embryos testing euploid would improve pregnancy rates.
This question has spawned numerous studies.
In an early study, aneuploidy diagnosed by CGH on biopsy of
both blastomere and trophectoderm biopsies resulted in 96% of
transferred embryos failing to implant [42]. Schoolcraft et al.,
found 51% of blastocysts of high-risk individuals (advanced
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Fig. 1 Early human development. a The zygote possesses one
pronucleus containing egg chromosomes and another pronucleus
containing sperm chromosomes. Both sets of chromosomes are
duplicated before the first cleavage to two cells. The morula forms at
the 8- to 16-cell stages, trapping one or two cells inside that undergo
commitment to become the inner cell mass (ICM) within the blastocyst.
The ICM gives rise to the fetus. The outer cells of the blastocyst become
committed to trophoblast, precursor to the placenta. b Theoretical
aneuploidy in early development. The scheme depicts the highest rate
of aneuploidy (purple cells) that could form the ICM from a euploid
cell (green) and produce a normal fetus. This theory is supported by
several lines of evidence, including chromosomal analyses that reveal
both aneuploid and euploid cells in human blastocysts
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age, history of IVF failures, or spontaneous abortion) were an-
euploid. And when euploid embryos were transferred, the preg-
nancy rate was 82% despite transferring fewer embryos in sub-
sequent cryothaw cycles [43]. In a randomized controlled trial,
155 patients with at least two blastocysts were randomized on
day 5. The clinical implantation rate was 80% in the CGH group
compared to 63% in untested controls (RR = 1.26, P = 0.002)
and the live birth rate was 66% in the CGH group compared to
48% in untested controls (RR= 1.39, P = 0.001) [19]. Further
studies have shown similar results in good prognosis patients.
TheBlastocyst Elective Selective Transfer (BEST) trial evaluated
the outcomes of 175 good prognosis patients randomized to
aneuploidy screening with elective single embryo transfer
(eSET) or double embryo transfer chosen by morphology alone.
The incidence of ongoing pregnancies per embryo transfer was
similar between the two groups (61 vs. 65%, (RR= 0.9, CI 0.7–
1.2) [44]. The cumulative delivery rates after fresh and first fro-
zen cycles were similar in both groups, 65 vs. 72%(P = 0.6) with
a drastic reduction in multiple births 1.6% compared to 47%
(P < 0.001) with reductions in preterm delivery, low birth rate,
and NICU admission [45].
The future
Acceptance of the fact that aneuploidy is common, perhaps
normal, in early cleaving human embryos will lead to the
development of paradigms about how much and what types
of aneuploidy are incompatible with further development. The
normal development of identical twins illustrates that only
50% of cells in an early embryo are needed for normal devel-
opment to offspring.
Data that support the existence of cellular mechanisms in
blastomeres that correct aneuploidy are limited, although a
recent report of haploid human parthenogenetic stem cells
converting to diploid stem cells during culture demonstrate
that robust chromosome copy number correcting mechanisms
develop at some point [46]. In fact, it is difficult to maintain a
line of haploid cells. Not surprising, they are smaller and di-
vide more slowly and never seem to reach 100% of the cell
population. To maintain a haploid state for studies, the re-
searchers needed to re-sort the cell population to select for
haploid genotypes every few cell doublings [43].
Similarly, data that support aneuploidy-correcting mecha-
nisms are also lacking—do those cells simply undergo pro-
grammed cell death at some point during development as is the
case for frog embryos [47]? Does chromothripsis occur in early
human embryos? Revealed by analyses of whole genome se-
quences of several cancer genome datasets, chromothripsis is a
complex process that includes chromosome duplications, dele-
tions, translocations, and inversions [15].
It may never be possible to fully assess the incidence of
aneuploidy in human embryos developing in utero, but the
degree of aneuploidy reported in spontaneous miscarriages
indicates it certainly exists, and increases with advancing ma-
ternal age. The possibility of designing conditions that sup-
press aneuploidy during early cleavage stages in vitro is an
intriguing one. The inclusion of small molecule inhibitors of
the aurora kinases in culture medium to at least cause a pause
during gap 2 is one possibility [48]. It is also possible that an
as yet to be discovered circadian signal helps control the cell
cycle, a possibility revealed by the detection of core circadian
oscillators on the microarrays of 8-cell human embryos [8].
More recent pilot studies of early cleavage stage mouse em-
bryos have revealed circadian expression of period 2 (manu-
script in preparation), supporting a possible novel role for this
core oscillator in early development.
Another approach is the inclusion of messenger RNA
constructs that encode naturally occurring, but perhaps lim-
ited, cell cycle check points, such as UHRF2, described
above, that may stabilize the onset of S phase. BUB1, a
kinase active in G2 that lines up on the kinetochore, opposes
aurora kinases to delay the onset of anaphase and help en-
sure proper chromosome segregation [49]. Suitable mRNA
constructs microinjected into eggs at the time of ICSI would
be translated during the ensuing couple of cell cycles before
being degraded. BUB1B was robustly detected on the mi-
croarrays of fresh, normal morphology 8-cell human embry-
os [8] but could be lacking in fragmented, more aneuploid
embryos.
Two decades of research on the incidence of aneuploidy
in human embryos has clearly documented that the majority,
if not all, embryos have some aneuploid blastomeres at some
time in early development, with the incidence increasing
with advanced maternal age [15–17]. There may be no ben-
efit to screening embryos from young donor eggs. The next
decade needs to focus on what aneuploid state is compatible
with normal fetal development, and what, if anything, can
in vitro fertilization laboratories do to adjust early develop-
ment toward the necessary euploid complement of cells for
robust embryonic development to healthy offspring. The ma-
jority of the cell cycle, DNA synthesis, and growth factor
family genes over-expressed in 8-cell human embryos have
more recently been reported to be circadianly expressed in
some mouse tissues [50]. This is in keeping with the noted
over-expression of the core circadian oscillators in 8-cell
embryos relative to cultured pluripotent stem cells [8].
Although primary cells in culture appear to maintain their
circadian oscillations for up to 2 weeks [51], newly fertilized
eggs may benefit from some, as yet unknown, circadian
signal support for the week they are commonly now held
in culture.
It is possible that IVF laboratories may be able to develop
corrective measures to alleviate the natural tendency toward
aneuploidy exhibited by human conceptions in their attempt to
rapidly multiply their genetic information.
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